IDH2 and melanoma: This study revealed a critical function of 5-hmC in melanoma development and directly linked the IDH and TET activity-dependent epigenetic pathway to 5-hmC mediated suppression of melanoma progression, suggesting a new strategy for epigenetic cancer therapy [13].